{{Rsnum
|rsid=2607839
|Gene=GRID1
|Chromosome=10
|position=87991916
|Orientation=minus
|GMAF=0.2167
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 6.2 | 38.1 | 55.8
| HCB | 1.5 | 35.0 | 63.5
| JPT | 1.8 | 20.4 | 77.9
| YRI | 13.6 | 39.5 | 46.9
| ASW | 5.3 | 40.4 | 54.4
| CHB | 1.5 | 35.0 | 63.5
| CHD | 1.8 | 20.2 | 78.0
| GIH | 19.8 | 49.5 | 30.7
| LWK | 10.9 | 39.1 | 50.0
| MEX | 0.0 | 20.7 | 79.3
| MKK | 6.4 | 40.4 | 53.2
| TSI | 5.9 | 41.2 | 52.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2607839
|Name_s=
|Gene_s=GRID1
|Feature=
|Evidence=PubMed ID:17537913
|Annotation=Risk or phenotype-associated allele: not stated Phenotype: Using a Quantitative Transmission Disequilibrium Test (QTDT), this variant was significantly associated with etoposide toxicity based upon IC50 values in cell lines from 30 parent-child trios. Study size: 87. Study population/ethnicity: 87 European descent Caucasians. Significance metric(s): p = 0.00002. Type of association: FA; GN.
|Drugs=etoposide
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA165109411
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2607839
|overall_frequency_n=102
|overall_frequency_d=128
|overall_frequency=0.796875
|n_genomes=53
|n_genomes_annotated=0
|n_haplomes=88
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}